XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Shareholders' Equity and Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Restricted Stock Units Activity
Time-based Restricted Stock Units (TRSUs)

The following table summarizes the Company’ TRSU activities for the three months ended September 30, 2024:
 
Number of Time-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual
Term (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20241,469,135 $29.13 1.66$54,901,575 
Granted29,000 $38.86 
Vested(63,411)$30.03 
Forfeited(16,838)$29.17 
Nonvested at September 30, 20241,417,886 $29.29 1.49$52,631,928 
The following table summarizes the Company’s PRSUs activities for the three months ended September 30, 2024:

 Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual Term
(Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2024344,125 $30.69 1.73$12,859,951 
Nonvested at September 30, 2024344,125 $30.69 1.47$12,773,920 
Summary of Stock Option Activities The following table summarizes the Company’s stock option activities for the three months ended September 30, 2024:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 202410,000 $9.07 0.13$283,000 
Exercised(10,000)$9.07 $265,267 
Outstanding at September 30, 20240.00 0.00$0.00 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:
Three Months Ended September 30,
2024
Volatility rate53.0%
Risk-free interest rate5.0%
Expected term1.3 years
Dividend yield0%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expense
The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows:
Three Months Ended September 30,
20242023
(in thousands)
Cost of goods sold$1,015 $212 
Research and development1,935 
Selling, general and administrative3,952 700 
$6,902 $918